32. Castello A, Franco D, Moral-Lopez P, Berlanga JJ, Alvarez E, et al. (2009) HIV- 1 protease inhibits Cap- and poly(A)-dependent translation upon eIF4GI and PABP cleavage. PLoS One 4: e7997. 33. Li X, Hu H, Shu L (2010) Predicting human immunodeficiency virus protease cleavage sites in nonlinear projection space. Mol Cell Biochem 339: 127–133. 34. Perez MA, Fernandes PA, Ramos MJ (2010) Substrate recognition in HIV-1 protease: a computational study. J Phys Chem B 114: 2525–2532. 35. Elroy-Stein O, Fuerst TR, Moss B (1989) Cap-independent translation of mRNA conferred by encephalomyocarditis virus 59 sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system. Proc Natl Acad Sci USA 86: 6126–6130. 36. Ratner L, Haseltine W, Patarca R, Livak KJ, Starcich B, et al. (1985) Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313: 277–284. 37. Connor RI, Chen BK, Choe S, Landau NR (1995) Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phago- cytes. Virology 206: 935–944. 38. He J, Choe S, Walker R, Di Marzio P, Morgan DO, et al. (1995) Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol 69: 6705–6711. 39. Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, et al. (2003) An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 11: 619–633. 40. Scheuner D, Song B, McEwen E, Liu C, Laybutt R, et al. (2001) Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol Cell 7: 1165–1176. HIV-1 Counteracts GCN2 Inhibitory Effect 41. Garcia-Merino I, de Las Cuevas N, Jimenez JL, Gallego J, Gomez C, et al. (2009) The Spanish HIV BioBank: a model of cooperative HIV research. Retrovirology 6: 27. 42. Gordon-Alonso M, Sala-Valdes M, Rocha-Perugini V, Perez-Hernandez D, Lopez-Martin S, et al. (2012) EWI-2 Association with alpha-Actinin Regulates T Cell Immune Synapses and HIV Viral Infection. J Immunol 189: 689–700. 43. Aldabe R, Feduchi E, Novoa I, Carrasco L (1995) Efficient cleavage of p220 by poliovirus 2Apro expression in mammalian cells: effects on vaccinia virus. Biochem Biophys Res Commun 215: 928–936. 44. Chonco L, Pion M, Vacas E, Rasines B, Maly M, et al. (2012) Carbosilane dendrimer nanotechnology outlines of the broad HIV blocker profile. J Control Release 161: 949–958. 45. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, et al. (2003) Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9: 493–501. 46. Khaleghpour K, Kahvejian A, De Crescenzo G, Roy G, Svitkin YV, et al. (2001) Dual interactions of the translational repressor Paip2 with poly(A) binding protein. Mol Cell Biol 21: 5200–5213. 47. Rittenhouse J, Turon MC, Helfrich RJ, Albrecht KS, Weigl D, et al. (1990) Affinity purification of HIV-1 and HIV-2 proteases from recombinant E. coli strains using pepstatin-agarose. Biochem Biophys Res Commun 171: 60–66. 48. Imataka H, Gradi A, Sonenberg N (1998) A newly identified N-terminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)-dependent translation. EMBO J 17: 7480–7489. 49. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–408. PLOS ONE | www.plosone.org 12 October 2012 | Volume 7 | Issue 10 | e47272